Deep search
Search
Images
Videos
Maps
News
Shopping
Copilot
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows.
These stocks are all trading near their 52-week lows, and could be attractive options to consider. They all possess promising growth opportunities in the long run. A $5,000 investment can go a long way,
Three Under-The-Radar Growth Stocks Poised To Double In 2025
Biote: Revolutionizing Hormone Optimization Biote (NYSE: BTMD) represents an innovative play in the growing hormone optimization market.
2 Brilliant Dividend Growth Stocks That Can Supercharge Your Portfolio
These characteristics make dividend growth stocks compelling investments in any market environment. The strategy's success stems from the financial discipline and steady execution these companies demonstrate,
12 Best Growth Stocks to Buy and Hold in 2025
The latest data from the job market in the United States came out on Friday and that has made the future of rate cuts even more uncertain.
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
Tapping into growth stocks at the right time and sticking with them for years to come can be one of the best ways to build wealth. But not all fast-growing companies end up being great long-term investments.
Got $3,000? 2 Monster Growth Stocks to Buy Right Now Without Hesitation
Here is a method to identify monster growth stocks in which you can invest $3,000 and let your money grow by 20-30% annually. The post Got $3,000? 2 Monster Growth Stocks to Buy Right Now Without Hesitation appeared first on The Motley Fool Canada.
Is uniQure N.V. (QURE) Among the Best Growth Stocks to Buy and Hold in 2025?
We recently compiled a list of the 12 Best Growth Stocks to Buy and Hold in 2025. In this article, we are going to take a look at where uniQure N.V.
My 3 Highest-Conviction Growth Stocks to Buy in 2025
Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 stocks » 1. Amazon Few companies enjoy as strong of a competitive moat as Amazon (NASDAQ: AMZN).
3 Growth Stocks to Buy in 2025
According to Grand View Research, the global AI market is projected to maintain a 36.6% compounded annual growth rate from now until 2030. The three growth stocks on this list all benefit from artificial intelligence.
22h
3 Incredible Growth Stocks I Can't Stop Buying
Recent market volatility has created buying opportunities in high-growth technology stocks that are transforming major ...
14m
Stock Market Today: Dow, S&P 500 and Nasdaq set for slightly higher open as CPI report looms; JPMorgan and Goldman Sachs launch earnings season
Follow all the action as the December CPI inflation report impacts bonds, stocks and forex, and Goldman Sachs and JPMorgan ...
1h
The Top 6 AI Stocks For 2025
Our Quant system has identified the top 6 companies leveraging fast-growing AI technologies with strong fundamentals for 2025 ...
2d
on MSN
3 Growth Stocks That Beat the S&P 500 in 2024 but Are Still Worth Buying in 2025
After a strong 2024, Archer Aviation can continue gaining altitude in the coming year (Archer Aviation): In addition to ...
24/7 Wall St. on MSN
8d
Buy These 3 Growth Stocks Before Inauguration Day
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...
1d
on MSN
Retail Stocks Drop Amid Investors’ Concerns Over Ability to Post Growth in 2025
Shares of retail stocks sank after companies including Abercrombie & Fitch, Macy’s and Urban Outfitters provided updates on ...
12h
My Top 10 High Dividend Yield Stocks For January 2025, One Yields Over 8%
Looking to boost your dividend portfolio? Learn about 10 high dividend yield companies with strong potential for growth in ...
1d
Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According to a Couple of Wall Street Analysts
If we assume all patients who began treatment with Casgevy last year progress to the administration stage, CRISPR and Vertex ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback